Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Rare And Severe Psoriasis Expert Network (IRASPEN) - A Prospective Registry With Genotype-Phenotype Correlation

NCT04359394 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.

NCT NCT04359394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04359394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Rare And Severe Psoriasis Expert Network (IRASPEN) - A Prospective Registry With Genotype-Phenotype Correlation
Lead sponsor
University Hospital, Basel, Switzerland
Phase
Observational
Overall status
Recruiting
Start date
September 22, 2021
Completion date
December 31, 2030
Enrollment
180 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

pustular psoriasis (pp)